We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-0.44%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.41B
AUM Growth
-$143M
Cap. Flow
-$108M
Cap. Flow %
-7.65%
Top 10 Hldgs %
40.58%
Holding
226
New
9
Increased
48
Reduced
78
Closed
10

Top Buys

Rank Stock Value
1
SO icon
Southern Company
SO
+$3.36M
2
PCOR icon
Procore
PCOR
+$1.51M
3
TJX icon
TJX Companies
TJX
+$1.37M
4
HD icon
Home Depot
HD
+$1.2M
5
HPQ icon
HP
HPQ
+$1.16M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$45.4M
2
WMT icon
Walmart Inc
WMT
+$20.5M
3
WST icon
West Pharmaceutical
WST
+$9.83M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.45M
5
TSLA icon
Tesla
TSLA
+$4.67M

Sector Composition

Rank Sector Weight
1 Technology 25.07%
2 Financials 17.13%
3 Consumer Staples 16.22%
4 Healthcare 10.07%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
201
Becton Dickinson
BDX
$46.9B
$252K 0.02%
1,100
– –
ALL icon
202
Allstate
ALL
$67.6B
$248K 0.02%
+1,200
New +$234K
CEG icon
203
Constellation Energy
CEG
$95.4B
$242K 0.02%
+1,200
New +$322K
KEYS icon
204
Keysight
KEYS
$55B
$240K 0.02%
1,600
– –
TROW icon
205
T. Rowe Price
TROW
$24.2B
$239K 0.02%
2,600
– –
PAYX icon
206
Paychex
PAYX
$41.9B
$237K 0.02%
1,536
-100
-6% -$14.7K
ET icon
207
Energy Transfer Partners
ET
$70B
$229K 0.02%
12,300
– –
DEO icon
208
Diageo
DEO
$48.8B
$220K 0.02%
2,100
-1,000
-32% -$113K
IP icon
209
International Paper
IP
$21.9B
$219K 0.02%
4,106
-548
-12% -$30K
TMUS icon
210
T-Mobile US
TMUS
$190B
$213K 0.02%
+800
New +$197K
EXC icon
211
Exelon
EXC
$47B
$207K 0.01%
+4,500
New +$188K
OTIS icon
212
Otis Worldwide
OTIS
$27.5B
$206K 0.01%
+2,000
New +$195K
LEVI icon
213
Levi Strauss
LEVI
$9.48B
$156K 0.01%
10,000
– –
SNAP icon
214
Snap
SNAP
$9.74B
$100K 0.01%
11,500
– –
ASML icon
215
ASML
ASML
$658B
– –
-300
Closed -$208K
CI icon
216
Cigna
CI
$74.5B
– –
-800
Closed -$221K
FBIN icon
217
Fortune Brands Innovations
FBIN
$6.22B
– –
-3,200
Closed -$219K
FDX icon
218
FedEx
FDX
$73.2B
– –
-750
Closed -$211K
KMI icon
219
Kinder Morgan
KMI
$69.9B
– –
-10,500
Closed -$288K
MSTR icon
220
Strategy Inc
MSTR
$35.7B
– –
-10,000
Closed -$2.9M
MU icon
221
Micron Technology
MU
$1.01T
– –
-4,700
Closed -$396K
RMD icon
222
ResMed
RMD
$31.2B
– –
-1,000
Closed -$229K
STZ icon
223
Constellation Brands
STZ
$22.4B
– –
-1,330
Closed -$294K
WST icon
224
West Pharmaceutical
WST
$24.5B
– –
-30,000
Closed -$9.83M
5 6 7 8
9

Similar funds

MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
WGAM
Wilkinson Global Asset Management New York $1.31B AUM 17.03% 1-Year Est. Return

Cullinan Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Cullinan Associates held 226 positions worth $1.41B, down 9.2% from $1.56B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Cullinan Associates withdrew a net $108M in Q1 2025, closing 10 positions and reducing 78 holdings. Its most notable exit was West Pharmaceutical, an estimated $9.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Cullinan Associates opened a new position in Procore worth $1.32M.

  • Cullinan Associates's largest Q1 2025 buy was Procore: 20,000 shares worth $1.32M.
  • Cullinan Associates added most to Southern Company in Q1 2025, an estimated $3.36M increase.
  • Cullinan Associates's biggest Q1 2025 reduction was Apple, cutting an estimated $45.4M.
  • Cullinan Associates fully exited West Pharmaceutical in Q1 2025, selling an estimated $9.83M.
  • Cullinan Associates's ten largest holdings make up 41% of its $1.41B portfolio in Q1 2025.
  • Cullinan Associates opened 9 new positions and closed 10 in Q1 2025.
  • Cullinan Associates's portfolio value fell 9.2% quarter-over-quarter to $1.41B.

Based on Cullinan Associates's 13F filing for Q1 2025, filed 22 Apr 2025.